SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -7.63358778626 | 1.31 | 1.32 | 1.17 | 434365 | 1.23734141 | CS |
4 | -0.14 | -10.3703703704 | 1.35 | 1.3599 | 1.15 | 421949 | 1.26580237 | CS |
12 | 0.01 | 0.833333333333 | 1.2 | 1.45 | 1.055 | 651514 | 1.21016524 | CS |
26 | 0.1 | 9.00900900901 | 1.11 | 1.72 | 0.81 | 1059872 | 1.28486178 | CS |
52 | -0.28 | -18.7919463087 | 1.49 | 1.9 | 0.4986 | 1041115 | 1.11668463 | CS |
156 | -9.25 | -88.4321223709 | 10.46 | 10.5899 | 0.4986 | 496875 | 1.77434858 | CS |
260 | 1.08 | 830.769230769 | 0.13 | 19.38 | 0.11 | 969315 | 4.66570255 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.